Cytospire Therapeutics
Cytospire Therapeutics is an antibodies developer for cancer treatment founded in 2023.
Country
CTO
Email Address
contact@cytospiretx.com
Founded Date
2023
Headquarters
Industry
Latest Funding Round Date
May 5, 2026
Latest Funding Round Amount (USD)
83,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
83,000,000
Official Website
Find more companies like Cytospire Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.